{"pmid":32298494,"title":"The role of children in the transmission of mild SARS-CoV-2 infection.","text":["The role of children in the transmission of mild SARS-CoV-2 infection.","We thank dr. Ludvigsson (1) on his effort to improve knowledge on SARS-CoV-2 infection in children. In trying to understand the spread of the disease, one of the most notable features is that only a small number of severe SARS-CoV-2 infections have involved children. The huge age disparity in disease severity might be one of the most stringent fundamental knowledge gaps.","Acta Paediatr","de Niet, A","Waanders, B L","Walraven, I","32298494"],"abstract":["We thank dr. Ludvigsson (1) on his effort to improve knowledge on SARS-CoV-2 infection in children. In trying to understand the spread of the disease, one of the most notable features is that only a small number of severe SARS-CoV-2 infections have involved children. The huge age disparity in disease severity might be one of the most stringent fundamental knowledge gaps."],"journal":"Acta Paediatr","authors":["de Niet, A","Waanders, B L","Walraven, I"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298494","week":"202016|Apr 13 - Apr 19","doi":"10.1111/apa.15310","source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1664266651234729985,"score":8.233237,"similar":[{"pmid":32273490,"title":"Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","text":["Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic.","Indian Pediatr","Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V","32273490"],"abstract":["Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic."],"journal":"Indian Pediatr","authors":["Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273490","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1663712077842219008,"score":57.11135},{"pmid":32279351,"title":"We urgently need guidelines for managing COVID-19 in children with comorbidities.","text":["We urgently need guidelines for managing COVID-19 in children with comorbidities.","I read with great interest the systematic review by Ludvigsson on the coronavirus disease 2019 (COVID-19) (1). The author needs to be complimented for a well-timed, rigorous and rapid synthesis of the evidence from the rather scant data available on how the virus affects children. The review, which focused on all papers published up to 19 March, drew important conclusions that have significant practical implications for those involved in providing acute care for children suffering from this disease.","Acta Paediatr","Dayal, Devi","32279351"],"abstract":["I read with great interest the systematic review by Ludvigsson on the coronavirus disease 2019 (COVID-19) (1). The author needs to be complimented for a well-timed, rigorous and rapid synthesis of the evidence from the rather scant data available on how the virus affects children. The review, which focused on all papers published up to 19 March, drew important conclusions that have significant practical implications for those involved in providing acute care for children suffering from this disease."],"journal":"Acta Paediatr","authors":["Dayal, Devi"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279351","week":"202016|Apr 13 - Apr 19","doi":"10.1111/apa.15304","source":"PubMed","topics":["Prevention","Diagnosis"],"weight":1,"_version_":1663890921981214721,"score":55.51399},{"pmid":32243729,"title":"The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.","text":["The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China.","In December 2019, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbroke in Wuhan, the capital city of Hubei province, China. The disease rapidly spread to other areas in China due to a huge population movement during the New Year Festival. Here, a 7-year-old child with SARS-CoV-2 infection in Chongqing, outside of Wuhan, Hubei province, was reported. This case suggested that children infected with SARS-CoV-2 are more likely to present milder manifestations than adults. The continuous positive real-time reverse transcription-polymerase chain reaction assay for SARS-CoV-2 in the child's throat swab sample indicated the isolation period for suspected child cases should be longer than 14 days.","Pediatr Pulmonol","Lin, Jilei","Duan, Jun","Tan, Tingdan","Fu, Zhou","Dai, Jihong","32243729"],"abstract":["In December 2019, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbroke in Wuhan, the capital city of Hubei province, China. The disease rapidly spread to other areas in China due to a huge population movement during the New Year Festival. Here, a 7-year-old child with SARS-CoV-2 infection in Chongqing, outside of Wuhan, Hubei province, was reported. This case suggested that children infected with SARS-CoV-2 are more likely to present milder manifestations than adults. The continuous positive real-time reverse transcription-polymerase chain reaction assay for SARS-CoV-2 in the child's throat swab sample indicated the isolation period for suspected child cases should be longer than 14 days."],"journal":"Pediatr Pulmonol","authors":["Lin, Jilei","Duan, Jun","Tan, Tingdan","Fu, Zhou","Dai, Jihong"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243729","week":"202014|Mar 30 - Apr 05","doi":"10.1002/ppul.24763","source":"PubMed","locations":["China","Wuhan","Hubei","Chongqing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663352135727710209,"score":55.07874},{"pmid":32212348,"title":"Why is COVID-19 so mild in children?","text":["Why is COVID-19 so mild in children?","There is an urgent need to understand why the course of the coronavirus that started in late 2019 (COVID-19) is affecting different groups of individuals with varying severity during the ongoing global pandemic. Greater knowledge of the disease, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), will help us to prioritise our limited health resources. Because the virus is new, and no vaccine is yet available, everyone is naive and susceptible to being infected with SARS-CoV2. The virus will continue to spread until an effective vaccine exists or sufficient members of our global population have been infected to establish herd immunity. At the moment, the best way to minimize loss of life and severe cases requiring intensive care is to try and shelter vulnerable groups of individuals and slow down the spread of the virus.","Acta Paediatr","Brodin, Petter","32212348"],"abstract":["There is an urgent need to understand why the course of the coronavirus that started in late 2019 (COVID-19) is affecting different groups of individuals with varying severity during the ongoing global pandemic. Greater knowledge of the disease, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), will help us to prioritise our limited health resources. Because the virus is new, and no vaccine is yet available, everyone is naive and susceptible to being infected with SARS-CoV2. The virus will continue to spread until an effective vaccine exists or sufficient members of our global population have been infected to establish herd immunity. At the moment, the best way to minimize loss of life and severe cases requiring intensive care is to try and shelter vulnerable groups of individuals and slow down the spread of the virus."],"journal":"Acta Paediatr","authors":["Brodin, Petter"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32212348","week":"202013|Mar 23 - Mar 29","doi":"10.1111/apa.15271","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663352134893043712,"score":53.595844},{"pmid":32232980,"title":"COVID-19 epidemic: disease characteristics in children.","text":["COVID-19 epidemic: disease characteristics in children.","In mid-December 2019, a disease caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which began in Wuhan, China, has spread throughout the country and many countries around the world. The number of children with coronavirus disease-2019 (COVID-19) has also increased significantly. Although information regarding the epidemiology of COVID-19 in children has accumulated, relevant comprehensive reports are lacking. The present article reviews the epidemiological characteristics of COVID-19 in children. This article is protected by copyright. All rights reserved.","J Med Virol","Jiatong, She","Lanqin, Liu","Wenjun, Liu","32232980"],"abstract":["In mid-December 2019, a disease caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which began in Wuhan, China, has spread throughout the country and many countries around the world. The number of children with coronavirus disease-2019 (COVID-19) has also increased significantly. Although information regarding the epidemiology of COVID-19 in children has accumulated, relevant comprehensive reports are lacking. The present article reviews the epidemiological characteristics of COVID-19 in children. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Jiatong, She","Lanqin, Liu","Wenjun, Liu"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232980","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25807","keywords":["COVID-19","Children","Epidemiological characteristics","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1663352135327154178,"score":51.039658}]}